Compare AJANTA PHARMA with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA DR. REDDYS LAB AJANTA PHARMA/
DR. REDDYS LAB
 
P/E (TTM) x 22.7 34.5 65.8% View Chart
P/BV x 5.4 4.2 129.9% View Chart
Dividend Yield % 0.8 0.6 131.7%  

Financials

 AJANTA PHARMA   DR. REDDYS LAB
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-21
DR. REDDYS LAB
Mar-21
AJANTA PHARMA/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs1,8835,515 34.1%   
Low Rs1,2583,028 41.6%   
Sales per share (Unadj.) Rs334.01,145.4 29.2%  
Earnings per share (Unadj.) Rs75.6114.5 66.0%  
Cash flow per share (Unadj.) Rs89.0188.4 47.2%  
Dividends per share (Unadj.) Rs9.5025.00 38.0%  
Avg Dividend yield %0.60.6 103.3%  
Book value per share (Unadj.) Rs346.11,053.2 32.9%  
Shares outstanding (eoy) m86.53166.30 52.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.73.7 126.1%   
Avg P/E ratio x20.837.3 55.7%  
P/CF ratio (eoy) x17.722.7 77.8%  
Price / Book Value ratio x4.54.1 111.9%  
Dividend payout %12.621.8 57.6%   
Avg Mkt Cap Rs m135,898710,289 19.1%   
No. of employees `000NANA-   
Total wages/salary Rs m5,48336,299 15.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m28,897190,475 15.2%  
Other income Rs m2602,914 8.9%   
Total revenues Rs m29,157193,389 15.1%   
Gross profit Rs m9,98638,699 25.8%  
Depreciation Rs m1,16112,288 9.4%   
Interest Rs m83970 8.5%   
Profit before tax Rs m9,00228,355 31.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,4639,319 26.4%   
Profit after tax Rs m6,53919,036 34.3%  
Gross profit margin %34.620.3 170.1%  
Effective tax rate %27.432.9 83.3%   
Net profit margin %22.610.0 226.4%  
BALANCE SHEET DATA
Current assets Rs m22,178145,503 15.2%   
Current liabilities Rs m8,38881,038 10.4%   
Net working cap to sales %47.733.8 141.0%  
Current ratio x2.61.8 147.3%  
Inventory Days Days5361 86.0%  
Debtors Days Days995 9.8%  
Net fixed assets Rs m18,912109,979 17.2%   
Share capital Rs m174832 20.9%   
"Free" reserves Rs m29,777174,319 17.1%   
Net worth Rs m29,951175,151 17.1%   
Long term debt Rs m166,299 0.3%   
Total assets Rs m41,090255,482 16.1%  
Interest coverage x109.830.2 363.4%   
Debt to equity ratio x00 1.5%  
Sales to assets ratio x0.70.7 94.3%   
Return on assets %16.17.8 205.8%  
Return on equity %21.810.9 200.9%  
Return on capital %30.316.2 187.6%  
Exports to sales %051.3 0.0%   
Imports to sales %018.1 0.0%   
Exports (fob) Rs mNA97,699 0.0%   
Imports (cif) Rs mNA34,420 0.0%   
Fx inflow Rs m18,09797,699 18.5%   
Fx outflow Rs m2,31534,420 6.7%   
Net fx Rs m15,78263,279 24.9%   
CASH FLOW
From Operations Rs m5,76335,703 16.1%  
From Investments Rs m-2,824-22,660 12.5%  
From Financial Activity Rs m-3,183-298 1,068.1%  
Net Cashflow Rs m-24412,858 -1.9%  

Share Holding

Indian Promoters % 70.5 26.7 263.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 21.4 49.9 42.8%  
FIIs % 8.6 25.2 34.3%  
ADR/GDR % 0.0 11.2 -  
Free float % 29.5 62.1 47.6%  
Shareholders   60,759 263,803 23.0%  
Pledged promoter(s) holding % 16.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   SUN PHARMA    CIPLA    LUPIN    ZYDUS LIFESCIENCES    AUROBINDO PHARMA    



Today's Market

Sensex Ends 111 Points Lower, Nifty Holds 15,750; ONGC, Reliance Crash, while ITC & Bajaj Twins Gain 4%(Closing)

After opening the day deep in the red, Indian share markets slowly recovered most of their losses and ended on a flat note.

Related Views on News

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

More Views on News

Most Popular

Best Monopoly Stocks to Own in 2022(Views On News)

Jun 18, 2022

Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.

The One Smallcap Stock I'll Recommend Now(Profit Hunter)

Jun 21, 2022

This aspect of investing has a very high weightage on your overall returns, but often gets ignored when winning stories are written.

Wait! Don't Buy the Smallcap 'Dip' Just Yet(Profit Hunter)

Jun 20, 2022

Why this may not be the best time to buy smallcaps.

5 Consistent Compounding Stocks Available at Discount. Time to Buy?(Views On News)

Jun 22, 2022

The good side of a market correction? Investors get consistent compounding stocks at a discount.

Looking for Value Stocks Amid Volatile Times? Consider These 5 Stocks(Views On News)

Jun 20, 2022

These value stocks have the potential to deliver good returns in the long run. Watch out for them.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Jul 1, 2022 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA - KWALITY PHARMA COMPARISON

COMPARE AJANTA PHARMA WITH

MARKET STATS